Searched for
ASKBIO ACQUISITION BY BAYER
Bayer’s gene and cell therapy pipeline aims to transform Parkinson’s, oncology, rare diseases and moreBayer, through its subsidiary Viralgen, is advancing cell and gene therapies (CGT) to cure diseases like Parkinson's, oncology, cardiovascu...- Bayer to acquire Asklepios Bio in foray into gene therapy worth up to $4 billionGermany’s Bayer will pay $2 billion upfront and up to an additional $2 billion in milestone payments contingent on development achievements...
- Load More